Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm?

British medical bulletin - 1 Jan 2011

Arribas-Ayllon Michael

Abstract excerpt

INTRODUCTION OR BACKGROUND: Genetic testing for rare Mendelian disorders represents the dominant ethical paradigm in clinical and professional practice. Predictive testing for Huntington's disease is the model against which other kinds of genetic testing are evaluated, including testing for Alzheimer's disease. SOURCES OF DATA: This paper retraces the historical development of ethical reasoning in relation to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoprotein E4
Share to Ethics, Medical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Truth Disclosure

Source

Identifiers

PMID: 21672937
DOI: 10.1093/bmb/ldr023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm?PMID 21672937Read ↗

Ethical, Legal and Social Implications of Susceptibility Genetic Testing for Late-Onset Neurodegenerative DiseasesSemantic proximity Read ↗

Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.Semantic proximity Read ↗

Genetic testing for neurodegenerative diseases: Ethical and health communication challenges.Semantic proximity Read ↗

Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.Semantic proximity Read ↗

Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics.Semantic proximity Read ↗

Understanding probabilistic risk in predisposition genetic testing for Alzheimer disease.Semantic proximity Read ↗

Predictive genetic testing for neurodegenerative conditions: how should conflicting interests within families be managed?Semantic proximity Read ↗

[Attitudes towards predictive genetic testing for Alzheimer's disease].Semantic proximity Read ↗

Disclosing incidental findings in genetics contexts: a review of the empirical ethical research.Semantic proximity Read ↗

Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II).Semantic proximity Read ↗

Assessing the Psychological Impact of Genetic Susceptibility TestingSemantic proximity Read ↗

Ethical considerations in psychiatric genetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.